Regional People with overweight, all classes of obesity, and T2D spotlighting the frequent concurrence of the two conditions Obesity x T2D overlap Wegovy and Zepbound are not FDA-approved to treat type 2 diabetes, but in clinical trials, in addition to losing weight, patients saw improvements in blood glucose levels
Initial BMI was 38 kg/m 2 , which was reduced to a steady state of 30 kg/m 2
Unintended consequences may occur as many systems are involved
Retatrutide takes this further by adding glucagon receptor activation to the mix, creating a triple agonist profile that produces enhanced weight loss effects
Can I use compounded tirzepatide instead of brand Zepbound
For appropriate patients, it may be part of a personalized treatment plan guided by a licensed clinician